WHO ICTRP trial
A collaborative and international study of bronchiectasis in Indigenous children
ACTRN12610000383066 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12610000383066 |
|---|---|
| Public title | A collaborative and international study of bronchiectasis in Indigenous children |
| Scientific title | Among Indigenous children with bronchiectasis, does weekly azithromycin (compared to weekly placebo) reduce rates of exacerbation? |
| Primary sponsor | Menzies School of Health Research |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | Australia;New Zealand |
| Conditions | Bronchiectasis in Indigenous children; Bronchiectasis in Indigenous children;Respiratory - Other respiratory disorders / diseases |
| Interventions | The study drug (azithromycin) is in powder format and will be reconstituted with 9ml of sterile water to syrup for oral use. This makes up to 40mg/ml. Children will receive a weekly dose of oral azithromycin once per week at 30mg/kg for up… |
| Registration date | Dec 5, 2010 |
| Target size | 68 |
| Secondary IDs | Menzies School of Health Research project number R205A |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: